Lampit ® (nifurtimox) – New orphan drug approval
August 7, 2020 - Bayer announced the FDA approval of Lampit (nifurtimox), in pediatric patients (birth to less than 18 years of age and weighing at least 2.5 kg) for the treatment of Chagas disease (American Trypanosomiasis), caused by Trypanosoma cruzi.
Top